TCL Archive ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies By Cancer History Project June 22, 2012
TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication By Cancer History Project February 17, 2012
TCL Archive How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval By Cancer History Project September 30, 2011
TCL Archive ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment By Cancer History Project September 23, 2011
TCL Archive Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific By Cancer History Project August 12, 2011
TCL Archive ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications By Cancer History Project July 22, 2011
ArticleSpotlight Article A Vote for Cancer: Tobacco Advertising and Presidential Elections By The Center for the Study of Tobacco and Society